Your browser doesn't support javascript.
loading
Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus?
Morton, C Oliver; White, P Lewis; Barnes, Rosemary A; Klingspor, Lena; Cuenca-Estrella, Manuel; Lagrou, Katrien; Bretagne, Stéphane; Melchers, Willem; Mengoli, Carlo; Caliendo, Angela M; Cogliati, Massimo; Debets-Ossenkopp, Yvette; Gorton, Rebecca; Hagen, Ferry; Halliday, Catriona; Hamal, Petr; Harvey-Wood, Kathleen; Jaton, Katia; Johnson, Gemma; Kidd, Sarah; Lengerova, Martina; Lass-Florl, Cornelia; Linton, Chris; Millon, Laurence; Morrissey, C Orla; Paholcsek, Melinda; Talento, Alida Fe; Ruhnke, Markus; Willinger, Birgit; Donnelly, J Peter; Loeffler, Juergen.
Afiliação
  • Morton CO; Western Sydney University, Sydney, Australia.
  • White PL; Public Health Wales Microbiology Cardiff, UK.
  • Barnes RA; Cardiff University School of Medicine, Cardiff.
  • Klingspor L; Karolinska University Hospital, Stockholm, Sweden.
  • Cuenca-Estrella M; Spanish National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
  • Lagrou K; University Hospitals Leuven, Department of Laboratory Medicine and National Reference Center for Mycosis, Leuven, Belgium, Belgium.
  • Bretagne S; Paris Diderot, Sorbonne Paris Cité University, Faculty of Medicine, Paris, France.
  • Melchers W; Radboud University Medical Centre, Nijmegen, Netherlands.
  • Mengoli C; University of Padua, Padua, Italy.
  • Caliendo AM; Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island and Aspergillus Technology Consortium, USA.
  • Cogliati M; Dip. Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy.
  • Debets-Ossenkopp Y; VU University Medical Centre, Amsterdam. The Netherlands.
  • Gorton R; Royal Free Hospital, London, United Kingdom.
  • Hagen F; Canisius-Wilhelmina Hospital, Nijmegen. The Netherlands.
  • Halliday C; Clinical Mycology Reference Laboratory, Pathology West, Westmead, Australia.
  • Hamal P; Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.
  • Harvey-Wood K; Southern General Hospital, Glasgow, Scotland. UK.
  • Jaton K; Institute of Microbiology, University Hospital of Lausanne, Switzerland.
  • Johnson G; Blizard Institute of Cell and Molecular Science, Queen Mary University of London, London, United Kingdom.
  • Kidd S; National Mycology Reference Centre, SA Pathology, Adelaide. Australia.
  • Lengerova M; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Lass-Florl C; Innsbruck Medical University, Innsbruck, Austria.
  • Linton C; UK Mycology Reference Lab, Public Health England, Bristol, United Kingdom.
  • Millon L; Laboratoire de Parasitologie-Mycologie Centre Hospitalier Universitaire, Besançon, France.
  • Morrissey CO; Alfred Health and Monash University, Melbourne, Australia.
  • Paholcsek M; University of Debrecen Medical and Health Science Center, Debrecen. Hungary.
  • Talento AF; Department of Clinical Microbiology, Trinity College, Dublin, Ireland.
  • Ruhnke M; Charité Medical School, University of Berlin, Berlin. Germany.
  • Willinger B; Medical University of Vienna, Vienna, Austria.
  • Donnelly JP; Radboud University Medical Centre, Nijmegen, Netherlands.
  • Loeffler J; Wuerzburg University, Wuerzburg, Germany.
Med Mycol ; 55(4): 402-413, 2017 Jun 01.
Article em En | MEDLINE | ID: mdl-28339744
ABSTRACT
A wide array of PCR tests has been developed to aid the diagnosis of invasive aspergillosis (IA), providing technical diversity but limiting standardisation and acceptance. Methodological recommendations for testing blood samples using PCR exist, based on achieving optimal assay sensitivity to help exclude IA. Conversely, when testing more invasive samples (BAL, biopsy, CSF) emphasis is placed on confirming disease, so analytical specificity is paramount. This multicenter study examined the analytical specificity of PCR methods for detecting IA by blind testing a panel of DNA extracted from a various fungal species to explore the range of Aspergillus species that could be detected, but also potential cross reactivity with other fungal species. Positivity rates were calculated and regression analysis was performed to determine any associations between technical specifications and performance. The accuracy of Aspergillus genus specific assays was 71.8%, significantly greater (P < .0001) than assays specific for individual Aspergillus species (47.2%). For genus specific assays the most often missed species were A. lentulus (25.0%), A. versicolor (24.1%), A. terreus (16.1%), A. flavus (15.2%), A. niger (13.4%), and A. fumigatus (6.2%). There was a significant positive association between accuracy and using an Aspergillus genus PCR assay targeting the rRNA genes (P = .0011). Conversely, there was a significant association between rRNA PCR targets and false positivity (P = .0032). To conclude current Aspergillus PCR assays are better suited for detecting A. fumigatus, with inferior detection of most other Aspergillus species. The use of an Aspergillus genus specific PCR assay targeting the rRNA genes is preferential.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aspergillus / Reação em Cadeia da Polimerase / Técnicas de Diagnóstico Molecular / Aspergilose Pulmonar Invasiva Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Med Mycol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aspergillus / Reação em Cadeia da Polimerase / Técnicas de Diagnóstico Molecular / Aspergilose Pulmonar Invasiva Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Med Mycol Ano de publicação: 2017 Tipo de documento: Article